Literature DB >> 12069176

Transdermal iontophoresis of tacrine in vivo.

Tarja Kankkunen1, Raimo Sulkava, Marja Vuorio, Kyosti Kontturi, Jouni Hirvonen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069176     DOI: 10.1023/a:1015374600683

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  6 in total

1.  Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride.

Authors:  Rashmi S Upasani; Ajay K Banga
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

2.  Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery.

Authors:  Ayyappa Chaturvedula; Dipty P Joshi; Carter Anderson; Russ Morris; Walter L Sembrowich; Ajay K Banga
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

3.  Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.

Authors:  Qingfang Xu; Sarah A Ibrahim; William I Higuchi; S Kevin Li
Journal:  Int J Pharm       Date:  2008-11-11       Impact factor: 5.875

Review 4.  Use of transdermal drug formulations in the elderly.

Authors:  Laure-Zoé Kaestli; Anne-Florence Wasilewski-Rasca; Pascal Bonnabry; Nicole Vogt-Ferrier
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 5.  Current advances in transdermal delivery of drugs for Alzheimer's disease.

Authors:  Thuy Trang Nguyen; Vo Van Giau; Tuong Kha Vo
Journal:  Indian J Pharmacol       Date:  2017 Mar-Apr       Impact factor: 1.200

6.  Enhanced Transdermal Delivery of Bisoprolol Hemifumarate via Combined Effect of Iontophoresis and Chemical Enhancers: Ex Vivo Permeation/In Vivo Pharmacokinetic Studies.

Authors:  Mahmoud H Teaima; Mohamed Azmi Ahmed Mohamed; Randa Tag Abd El Rehem; Saadia A Tayel; Mohamed A El-Nabarawi; Shahinaze A Fouad
Journal:  Pharmaceutics       Date:  2021-05-10       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.